logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Abram Scientific Secures $1 Million National Science Foundation (Nsf) Small Business Innovation Research (Sbir) Phase Ii Grant

Abram Scientific Secures $1 Million National Science Foundation (Nsf) Small Business Innovation Research (Sbir) Phase Ii Grant

04/06/21, 12:20 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Abram Scientific today announced it has secured $1 million in non-dilutive funding with an NSF SBIR Phase II Grant in support of the clinical development of the CoagCare System. The system is intended to aid in the evaluation of blood clotting disorders and help define appropriate treatment for patients undergoing trauma and surgical procedures in the hospital. This work is supported by America's Seed Fund powered by the NSF under Grant No. 2050272.

Company Info

Company
Abram
Location
san francisco, california, united states
Additional Info
Based in the San Francisco Bay Area, Abram Scientific was founded by Dr. Abhishek Ramkumar who invented the CoagCare platform technology. The technology is covered by US and international patents and applications. Abram's leadership includes medical device industry veterans with >40 years experience: Dr. Edward Brennan, CEO and Mr. James Merselis, Chairman. Abram's CoagCare System is not yet cleared by the U.S. Food and Drug Administration for marketing in the United States.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.